OBJECTIVE: This study tested whether the quality of the patient-rated working alliance, measured early in treatment, predicted subsequent symptom reduction in chronically depressed patients. Secondarily, the study assessed whether the relationship between early alliance and response to treatment differed between patients receiving cognitive behavioral analysis system of psychotherapy (CBASP) vs. brief supportive psychotherapy (BSP). METHOD: 395 adults (57% female; Mage = 46; 91% Caucasian) who met criteria for chronic depression and did not fully remit during a 12-week algorithm-based, open-label pharmacotherapy trial were randomized to receive either 16-20 sessions of CBASP or BSP in addition to continued, algorithm-based antidepressant medication. Of these, 224 patients completed the Working Alliance Inventory-Short Form at Weeks 2 or 4 of treatment. Blind raters assessed depressive symptoms at 2-week intervals across treatment using the Hamilton Rating Scale for Depression. Linear mixed models tested the association between early alliance and subsequent symptom ratings while accounting for early symptom change. RESULTS: A more positive early working alliance was associated with lower subsequent symptom ratings in both the CBASP and BSP, F(1, 1236) = 62.48, p < .001. In addition, the interaction between alliance and psychotherapy type was significant, such that alliance quality was more strongly associated with symptom ratings among those in the CBASP treatment group, F(1, 1234) = 8.31, p = .004. CONCLUSIONS: The results support the role of the therapeutic alliance as a predictor of outcome across dissimilar treatments for chronic depression. Contrary to expectations, the therapeutic alliance was more strongly related to outcome in CBASP, the more directive of the 2 therapies. PsycINFO Database Record (c) 2013 APA, all rights reserved.
RCT Entities:
OBJECTIVE: This study tested whether the quality of the patient-rated working alliance, measured early in treatment, predicted subsequent symptom reduction in chronically depressedpatients. Secondarily, the study assessed whether the relationship between early alliance and response to treatment differed between patients receiving cognitive behavioral analysis system of psychotherapy (CBASP) vs. brief supportive psychotherapy (BSP). METHOD: 395 adults (57% female; Mage = 46; 91% Caucasian) who met criteria for chronic depression and did not fully remit during a 12-week algorithm-based, open-label pharmacotherapy trial were randomized to receive either 16-20 sessions of CBASP or BSP in addition to continued, algorithm-based antidepressant medication. Of these, 224 patients completed the Working Alliance Inventory-Short Form at Weeks 2 or 4 of treatment. Blind raters assessed depressive symptoms at 2-week intervals across treatment using the Hamilton Rating Scale for Depression. Linear mixed models tested the association between early alliance and subsequent symptom ratings while accounting for early symptom change. RESULTS: A more positive early working alliance was associated with lower subsequent symptom ratings in both the CBASP and BSP, F(1, 1236) = 62.48, p < .001. In addition, the interaction between alliance and psychotherapy type was significant, such that alliance quality was more strongly associated with symptom ratings among those in the CBASP treatment group, F(1, 1234) = 8.31, p = .004. CONCLUSIONS: The results support the role of the therapeutic alliance as a predictor of outcome across dissimilar treatments for chronic depression. Contrary to expectations, the therapeutic alliance was more strongly related to outcome in CBASP, the more directive of the 2 therapies. PsycINFO Database Record (c) 2013 APA, all rights reserved.
Authors: Paul Crits-Christoph; Mary Beth Connolly Gibbons; Jessica Hamilton; Sarah Ring-Kurtz; Robert Gallop Journal: J Consult Clin Psychol Date: 2011-06
Authors: Christian A Webb; Robert J DeRubeis; Jay D Amsterdam; Richard C Shelton; Steven D Hollon; Sona Dimidjian Journal: J Consult Clin Psychol Date: 2011-06
Authors: Michael J Constantino; Margaret E Marnell; Abigail J Haile; Susanna N Kanther-Sista; Kari Wolman; Laurel Zappert; Bruce A Arnow Journal: Psychotherapy (Chic) Date: 2008-06
Authors: James H Kocsis; Alan J Gelenberg; Barbara O Rothbaum; Daniel N Klein; Madhukar H Trivedi; Rachel Manber; Martin B Keller; Andrew C Leon; Steven R Wisniewski; Bruce A Arnow; John C Markowitz; Michael E Thase Journal: Arch Gen Psychiatry Date: 2009-11
Authors: I Elkin; M T Shea; J T Watkins; S D Imber; S M Sotsky; J F Collins; D R Glass; P A Pilkonis; W R Leber; J P Docherty Journal: Arch Gen Psychiatry Date: 1989-11
Authors: John C Markowitz; James H Kocsis; Paul Christos; Kathryn Bleiberg; Alexandra Carlin Journal: J Nerv Ment Dis Date: 2008-06 Impact factor: 2.254
Authors: Daniel N Klein; Joseph E Schwartz; Neil J Santiago; Dina Vivian; Carina Vocisano; Louis G Castonguay; Bruce Arnow; Janice A Blalock; Rachel Manber; John C Markowitz; Lawrence P Riso; Barbara Rothbaum; James P McCullough; Michael E Thase; Frances E Borian; Ivan W Miller; Martin B Keller Journal: J Consult Clin Psychol Date: 2003-12
Authors: Jessica A Chen; John C Fortney; Hannah E Bergman; Kendall C Browne; Kathleen M Grubbs; Teresa J Hudson; Patrick J Raue Journal: Psychol Serv Date: 2019-02-11
Authors: Ryan A Mace; David A Gansler; Michael K Suvak; Carla M Gabris; Patricia A Areán; Patrick J Raue; George S Alexopoulos Journal: J Affect Disord Date: 2017-03-07 Impact factor: 4.839